Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The BRIGHT Study, an Open Label, Single-arm, Interventional, Multicenter, Prospective Study of the Diagnostic Feasibility of the HALO System, Designed to Evaluate the Safety and Performance of the HALO SYSTEM in Subjects With Diabetes Mellitus

NCT07745998 is registered in ClinicalTrials.gov with Indigo Diabetes NV as lead sponsor.

NCT NCT07745998
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07745998 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The BRIGHT Study, an Open Label, Single-arm, Interventional, Multicenter, Prospective Study of the Diagnostic Feasibility of the HALO System, Designed to Evaluate the Safety and Performance of the HALO SYSTEM in Subjects With Diabetes Mellitus
Lead sponsor
Indigo Diabetes NV
Phase
Not applicable
Overall status
Not yet recruiting
Start date
December 31, 2026
Completion date
June 30, 2027
Enrollment
12 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, diabetes mellitus - type 1, diabetes mellitus - type 2, hyperglycaemia (diabetic), hypoglycemia (diabetic), ketoacidosis, diabetic